Baxter Healthcare Corporation is recalling 33,600 bags of 0.9% Sodium Chloride Injection USP (100 mL) due to Current Good Manufacturing Practice (CGMP) deviations. This prescription medication, commonly known as saline solution, is used for fluid and electrolyte replacement and as a priming solution in hemodialysis. The recall was initiated because the products may not have been manufactured according to required quality standards, which could compromise the safety or effectiveness of the drug. These products were distributed specifically to facilities in Texas and Mississippi.
The deviations from good manufacturing practices mean the product may not meet its required quality or safety specifications. While no specific injuries or adverse events have been reported, using medication that fails to meet quality standards could lead to ineffective treatment or unexpected reactions.
Contact healthcare provider or pharmacist and return for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.